title: [The use of biological therapy in the SAPHO syndrome].
authors.forename: Mirna
authors.initials: M
authors.lastname: Sentíc
authors.forename: Ivan
authors.initials: I
authors.lastname: Padjen
authors.forename: Marko
authors.initials: M
authors.lastname: Baresić
authors.forename: Branimir
authors.initials: B
authors.lastname: Anić
mesh_terms: D020083:Acquired Hyperostosis Syndrome / Q000188:drug therapy*; D001691:Biological Therapy; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D007074:Immunoglobulin G; D053590:Interleukin 1 Receptor Antagonist Protein; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept